🧬 Dinkov DistilledOutline

Cancer as a Metabolic Disease

Published: 7/1/2025

Cancer as a Metabolic Disease

For over a century, the story of cancer has been written as a genetic tragedy. We are told that random mutations corrupt a cell's DNA, hijacking its programming and causing it to multiply uncontrollably. This Somatic Mutation Theory has dominated research and treatment, leading to therapies designed to poison or irradiate the mutated cells into submission. The bioenergetic view challenges this dogma at its very foundation, proposing a different, far more hopeful story: cancer is not primarily a genetic disease, but a metabolic one.

The evidence for this paradigm shift is overwhelming and elegant. The defining feature of nearly all cancer cells is not a specific gene, but a specific behavior: they have abandoned efficient, oxygen-based mitochondrial respiration in favor of a primitive, inefficient energy-production strategy called fermentation.

This metabolic failure is not a consequence of the cancer; it is the foundational cause. The genetic mutations we observe are the downstream result of a chronically disrupted, low-energy cellular environment. We see this in a series of landmark experiments:

  • The Nuclear Transfer: When you take the "mutated" nucleus from a cancer cell and place it into a healthy cytoplasm with functional mitochondria, its dysregulated growth becomes regulated again. The "bad" genes, in a good environment, behave.

  • The Precedence of Dysfunction: Metabolic derangement has been shown to precede the accumulation of cancerous mutations by three or four cell cycles. The energy crisis comes first.

This reframing changes everything. If cancer is a metabolic disease rooted in mitochondrial dysfunction, then the solution is not simply to kill the cell. In fact, the cellular debris and inflammation created by killing cancer with chemotherapy can put the body further into a reduced, pro-cancer state, explaining why systemic cancer can emerge even after a primary tumor is gone.

The true goal must be to address the underlying metabolic conditions that allow cancer to thrive. The following sections will explore the specifics of this metabolic failure: the Warburg Effect, and the central role played by the cell's redox state, lactate production, and local pH.